Activist investor Starboard accuses Pfizer of strong-arming former execs into backing CEO Bourla ahead of strategy meeting
Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting with activist investor Starboard Value, Pfizer's former CEO and CFO publicly changed their tune after being threatened with litigation by Pfizer,
Pfizer chief executive Albert Bourla plans to meet Starboard Value, said people familiar with the matter, as the activist ...
Activist investor Starboard Value has acquired a significant stake in Pfizer, valued at around $1 billion, as it aims to ...
The ongoing corporate battle between Pfizer and activist investment firm Starboard Value escalated on Thursday when Starboard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback